21H·

New purchase - CapsoVision

📈 New purchase - CapsoVision


I am with CapsoVision an innovative MedTech company that is setting new standards with its 360° capsule endoscopy. No external recorder required, full perspective - and already FDA-approved & in use in the USA.


💡 Why this investment?

  • Technological advantage compared to traditional solutions (e.g. PillCam from Medtronic)
  • Already cooperating with Pentax Medical
  • Focus on early detection & diagnosticsa megatrend in the healthcare sector
  • Low market capitalization (~180m USD) with a lot of upside potential


🚀 Vision:

If CapsoVision reaches USD 50-100m sales in the medium term, a multiple in the share price is possible. In the long term I see 10-25 USD+ per share as realistic - depending on market penetration and access to capital, of course.


I think: exciting small cap story with disruptive potential - What do you think?

👉 Do you know the company? How do you rate the opportunities & risks?

Please leave your opinion!


#aktien
#investieren
#MedTech
#CapsoVision
#SmallCap
#langfristig
#innovation
#getquin
#medizin
#medizintechnik
#pharma
#medical
#zukunft
$NOVO B (+3,4 %)
$PLTR (+2,64 %)
$AMD (+0,34 %)
$NOVN (+0,5 %)

18.07
CV
Acheté à 4,76 $US
4
Participez à la conversation